Literature DB >> 29523495

Predicting outcome and improving treatment for Lassa fever.

Thomas W Geisbert1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29523495     DOI: 10.1016/S1473-3099(18)30116-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  3 in total

1.  Beyond Lassa Fever: Systemic and structural barriers to disease detection and response in Sierra Leone.

Authors:  Hana Rohan
Journal:  PLoS Negl Trop Dis       Date:  2022-05-19

2.  Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Authors:  Junki Maruyama; Elizabeth J Mateer; John T Manning; Rachel Sattler; Alexey V Seregin; Natalya Bukreyeva; Frank R Jones; Joseph P Balint; Elizabeth S Gabitzsch; Cheng Huang; Slobodan Paessler
Journal:  Vaccine       Date:  2019-09-24       Impact factor: 3.641

3.  Genomic Analysis of Lassa Virus during an Increase in Cases in Nigeria in 2018.

Authors:  Katherine J Siddle; Philomena Eromon; Kayla G Barnes; Samar Mehta; Judith U Oguzie; Ikponmwosa Odia; Stephen F Schaffner; Sarah M Winnicki; Rickey R Shah; James Qu; Shirlee Wohl; Patrick Brehio; Christopher Iruolagbe; John Aiyepada; Eghosa Uyigue; Patience Akhilomen; Grace Okonofua; Simon Ye; Tolulope Kayode; Fehintola Ajogbasile; Jessica Uwanibe; Amy Gaye; Mambu Momoh; Bridget Chak; Dylan Kotliar; Amber Carter; Adrianne Gladden-Young; Catherine A Freije; Omigie Omoregie; Blessing Osiemi; Ekene B Muoebonam; Michael Airende; Rachael Enigbe; Benevolence Ebo; Iguosadolo Nosamiefan; Paul Oluniyi; Mahan Nekoui; Ephraim Ogbaini-Emovon; Robert F Garry; Kristian G Andersen; Daniel J Park; Nathan L Yozwiak; George Akpede; Chikwe Ihekweazu; Oyewale Tomori; Sylvanus Okogbenin; Onikepe A Folarin; Peter O Okokhere; Bronwyn L MacInnis; Pardis C Sabeti; Christian T Happi
Journal:  N Engl J Med       Date:  2018-10-17       Impact factor: 91.245

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.